President-elect Donald Trump’s second term could spell big gains for this stock, according to Bernstein.
Category: Uncategorized
This lithium stock is an under-the-radar turnaround story, according to the charts
Frank Cappelleri breaks down the charts in Albemarle.
Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy’s playbook
The board of Acurx Pharmaceuticals has approved the purchase of up to $1 million in bitcoin to hold as a treasury reserve asset.
A bearish options trade on Apple as stock struggles to keep up with broader market
Tony Zhang updates the winning trade he made in September.
Goldman says this uranium miner could rally on nuclear demand, low geopolitical risk exposure
Uranium prices are expected to remain elevated as demand outstrips supply.
Oppenheimer’s top stock picks heading into year-end
There are only a few weeks left in the year, and some stocks may still be due for gains, according to Oppenheimer.
Goldman thinks Nvidia is going to beat and so does the options market
One of the most anticipated earnings releases of the quarter could spark big moves.
Here are Wednesday’s biggest analyst calls: Nvidia, Apple, Netflix, Microsoft, Robinhood, Amazon, Dell, Chewy & more
Here are Wednesday’s biggest calls on Wall Street.
Pivotal Research hikes Netflix price target to Street-high $1,100 after Tyson-Paul fight
The record-breaking numbers for the match between Mike Tyson and Jake Paul show Netflix’s preeminence in the streaming sector, per Pivotal Research.
Piper Sandler says this tech stock that’s up 700% in 2024 has more room to run
The firm initiated coverage with an overweight rating and $400 price target on shares, implying shares could climb an additional 24.5% from Tuesday’s close.